Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
177Lu and 225Ac dose escalation using a novel class of PSMA ...
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies ...
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle ...
(PDF) Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives ...
Figure 1 from A Consensus Time for Performing Quality Control of 225Ac ...
Table 2 from A Consensus Time for Performing Quality Control of 225Ac ...
Table 1 from A Consensus Time for Performing Quality Control of 225Ac ...
Retention times of rhPSMA radioligands, PSMA-617, and PSMA-I&T in AMSEC ...
(PDF) Cyclotron production of 225Ac from an electroplated 226Ra target
Production of 225Ac for medical application from 232Th-metallic targets ...
Method and device for producing medical isotope 225Ac - Eureka | Patsnap
RhPSMA for Prostate Cancer Treatment | Open Medscience
Table 3 from Development of 225Ac Radiopharmaceuticals: TRIUMF ...
Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted ...
Technology | Blue Earth Therapeutics
Chemical structure of the Lu-rhPSMA-10 isomers, differing in the ...
Blue Earth Therapeutics reports encouraging findings from preclinical ...
225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell ...
Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative ...
Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with ...
Targeted Alpha Therapy: Exploring the Clinical Insights into [225Ac]Ac ...
Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According ...
(PDF) Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu ...
Design of 225Ac-PSMA for targeted alpha therapy in prostate cancer - PMC
Targeted Alpha Therapy: All We Need to Know about 225Ac’s Physical ...
Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in ...
Signaling Network Response to α-Particle–Targeted Therapy with the ...
Structural formula of [ 225 Ac]Ac-PSMA-I&T, with DOTAGA as a chelator ...
ESMO 2025: TiP – PSMAcTION: A Phase 2/3 Randomized Trial of 225Ac-PSMA ...
Specific Activity of 225Ac-PSMA Targeting Agents Impacts ...
Frontiers | Alpha-peptide receptor radionuclide therapy using actinium ...
[225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer ...
[225Ac]Ac-PSMA for the Treatment of Metastatic Castration-Resistant ...
The principal production routes for 225 Ac. | Download Scientific Diagram
(PDF) Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for ...
Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of ...
a-Ray Spectrum of 225 Ac. | Download Scientific Diagram
Navigating the safety profile of Actinium-225 targeted alpha therapy: a ...
Blue Earth Therapeutics宣布了225Ac-rhPSMA-10.1用于α疗法治疗前列腺癌的临床前评估良好结果 - 中国核技术网
225Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine ...
225Ac-Psma-R2 – Aplicación en terapia e investigaciones clínicas actuales
BET Posters and Presentations
Blue Earth Therapeutics Announces Promising Results of Preclinical ...
Neutronic Study on Ac-225 Production for Cancer Therapy by (n,2n ...
Biodistribution of (A) [ 225 Ac]Ac-mcp-M-alb-PSMA and (B) [ 225 ...
Figure 1 from 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of ...
Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model ...
(PDF) Development of [225Ac]Ac-PSMA-I for Targeted Alpha Therapy ...
Assessment of emission data and transmission factors supporting ...
Table 1 from Targeted Alpha Therapy: All We Need to Know about 225Ac’s ...
Newport LLC on LinkedIn: RadioMedix Inc. Announces the Acquisition of ...
ASTRO 2023: Detection Rate of 18F-rhPSMA-7.3 PET in Patients with ...
PSMA-Directed Theranostics in Prostate Cancer
Semi-Permanent Mass Production of Ac-225 for Cancer Therapy by the (3n ...
Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in ...
Radiochemical yields (RCY, %) for 225 Ac III radiolabeling reactions of ...
A Novel Model-Based Planar Reconstruction Method for Accurate Activity ...
Deescalated 225Ac-PSMA-617 Versus 177Lu/225Ac-PSMA-617 Cocktail Therapy ...
225Ac-FL-020 is a novel PSMA-targeting radionuclide drug conjugate (RDC ...
Figure 1 from Targeted Alpha Therapy: All We Need to Know about 225Ac’s ...
Effectiveness of 225Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR ...
Conjugation and radiolabelling of [225Ac]Ac-macropa-tzPEG3Sq-ch806, a ...
Optimized reaction conditions of labeling [ 225 Ac]Ac-PSMA-I&T ...
225Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide ...
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the ...
Hematological toxicity of [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 in ...
Figure 2 from 225Ac-Labeled Antibody for Fibroblast Activation Protein ...
World Theranostics Presentation: TTV on F18-PSMA PET to monitor ...
What is the efficacy of Alpha particle radio pharmaceuticals, such as ...
SNMMI 2024: 225Ac-PSMA / 177Lu-PSMA Tandem Therapy for Metastatic ...
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac ...
Figure 2 from Salivary Gland Toxicity of PSMA-Targeted Radioligand ...
PPT - Tri-Lab Research Effort to Provide Accelerator-Produced 225 Ac ...
Albumin-Mediated Size Exclusion Chromatography: The Apparent Molecular ...
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission ...
Labeling process and quality control results of 225Ac-PSMA-617 for ...
225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic ...
Study launches of 225Ac-PSMA-Trillium in mCRPC | Urology Times
Figure 2 from Comparative Analysis of Morphological and Functional ...
Diagnostic Performance and Safety of Positron Emission Tomography with ...
SUO 2022: Diagnostic Performance and Safety of 18F-rhPSMA-7.3 PET in ...
Evolving role of 225Ac-PSMA radioligand therapy in metastatic ...
MTTI 225Ac-EBTATE Proves Extremely Potent in Combating Neuroendocrine ...
ASCO GU 2025: ACCEL: [Ac-225]-PSMA-62 Phase Ia/Ib/II Clinical Trial to ...
Slide 26
Preclinical Evaluation of 177Lu-rhPSMA-10.1, a Radiopharmaceutical for ...
Taking on Unmet Need in Castration-Resistant Prostate Cancer
Extrapolating organ and tumor doses for 225Ac-PSMA-I&T radionuclide ...
Long-Term Safety and Survival Outcomes of [225Ac]Ac-PSMA (Prostate ...
AUA 2024: Phase I Dose-Escalation Trial of Multiple and Fractionated ...
